NEKTAR THERAPEUTICS's ticker is NKTR and the CUSIP is 640268108. A total of 149 filers reported holding NEKTAR THERAPEUTICS in Q2 2023. The put-call ratio across all filers is 0.11 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $108 | +3.8% | 180,630 | 0.0% | 0.01% | 0.0% |
| Q2 2023 | $104 | -86.8% | 180,630 | -48.0% | 0.01% | -88.6% |
| Q4 2022 | $786 | -99.9% | 347,612 | -27.0% | 0.04% | -52.2% |
| Q3 2022 | $1,525,000 | -7.3% | 476,412 | +10.0% | 0.09% | -25.8% |
| Q2 2022 | $1,645,000 | +317.5% | 433,000 | +493.1% | 0.12% | +376.9% |
| Q1 2022 | $394,000 | +44.3% | 73,010 | +234.6% | 0.03% | -82.8% |
| Q2 2015 | $273,000 | – | 21,820 | – | 0.15% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Camber Capital Management LP | 2,000,000 | $67,200,000 | 3.35% |
| First Light Asset Management, LLC | 763,403 | $25,650,000 | 3.33% |
| BRIDGER MANAGEMENT, LLC | 1,238,489 | $41,613,000 | 3.29% |
| Rhenman & Partners Asset Management AB | 734,445 | $24,677,000 | 2.89% |
| BB BIOTECH AG | 2,020,676 | $67,895,000 | 1.71% |
| Gs Investments, Inc. | 54,200 | $1,821,120,000 | 1.43% |
| Artal Group S.A. | 900,000 | $30,240,000 | 1.24% |
| Cormorant Asset Management, LP | 500,000 | $16,800,000 | 1.14% |
| TOBAM | 640,547 | $21,522,000 | 1.09% |
| Bellevue Group AG | 430,026 | $14,449,000 | 0.80% |